ArticleFrontiers in medicine2026
Case Report: A diabetic ketoacidosis in adolescents complicated with rhino-orbital-cerebral mucormycosis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rhino-orbital-cerebral mucormycosis (ROCM) is an aggressive infection caused by Mucorales fungi, with rapid progression, high mortality, and disability. The insidious onset and atypical early symptoms predispose the condition to misdiagnosis or delayed diagnosis. There are no evidence-based guidelines for the diagnosis and treatment of mucormycosis in children. This case report describes the entire diagnostic and treatment process for a 14-year-old female patient with type 1 diabetes mellitus (T1DM) who developed ROCM following diabetic ketoacidosis (DKA). It highlights the key role of clinical pharmacists in multidisciplinary collaboration, pharmacological evaluation, antifungal regimen optimization, and medication monitoring. Case description: A 14-year-old female patient was admitted to the hospital due to persistent chest pain for 5 days and was diagnosed with T1DM complicated with DKA. During the treatment of DKA, the patient suddenly developed high fever, nasal congestion, progressive eyelid and periorbital swelling, headache, and cranial nerve dysfunction. Plasma mNGS and nasal mucosa biopsy both detected Rhizopus delemar, confirming ROCM. The initial treatment was liposomal amphotericin B (5 mg/kg/d) combined with nasal endoscopic debridement, the infection was initially controlled. However, on the 16th day, anemia aggravated (Hb 84 g/L), and severe hypokalemia (K Conclusion: This case demonstrates that in adolescent patients with T1DM who develop ROCM following DKA, non-specific prodromal symptoms such as headache, facial swelling, and nasal congestion should be closely monitored. Early implementation of a multi-modal diagnostic approach combining mNGS and tissue biopsy is necessary. Based on organ function, drug toxicity, and pharmacokinetic characteristics, individualized antifungal regimens that balance efficacy and target organ protection should be formulated. Clinical pharmacists play a crucial role in the management of severe fungal infections by participating in diagnostic collaboration, regimen optimization, and continuous safety monitoring, thereby enhancing the scientificity, safety, and precision of treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.